TCL Archive FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer. July 27, 2007
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive In Brief: Huntsman Cancer Institute Joins NCCN: Howard cancer Center To Honor Mandela November 7, 1997
TCL Archive In Brief: New DRCCA Recruits: Cullen Will Be Greenwalds’s Deputy, Frelick To Become CCOP Project Officer April 2, 1982